HealthcareAegerion Pharma CFO bids adieuMay 14, 2015 5:11 PM ETNovelion Therapeutics Inc. (NVLNF) StockNVLNFBy: Douglas W. House, SA News EditorAegerion Pharmaceuticals' (AEGR) Chief Financial Officer Mark Fitzpatrick resigns. Chief Accounting Officer David Aubuchon will replace him. The transition will occur in the next 30 days.Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgNVLNF--Novelion Therapeutics Inc.Trending AnalysisTrending News